Key Dates

Related Announcements

RFA-CA-20-039 - Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to add    that "no late applications will be accepted" for the July 22, 2020, Application Due Date in RFA-CA-20-039 "Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)".

The following section of RFA-CA-20-039 has been amended:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due Date(s): July 22, 2020

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Should correctly read (in italics):

Application Due Date(s): July 22, 2020 

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

   No late applications will be accepted for this FOA. 

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]